RAKIDUAM - Knowledge

29 Millennium Institute on Immunology and Immunotherapy (IMII) The mission of the IMII is the integrated study of the immune system in order to generate new high impact knowledge, which can be transferred to therapy, prophylactic strategies such as vaccina- tions and methods to diagnose illnesses with an immune and inflammatory component that affect the human population. The illnesses studied by the IMII include cancer, autoimmunity, hypertension and infections. The investigation carried out at the Center is done in a multidisciplinary manner, through the colla- boration of biochemists, doctors, medical technologists, nurses and veterinarians, among others. In turn, the IMII has around 150 young researchers (undergraduate, masters, doctorate, post doctora- te), housed in over 15 independent research laboratories, which are well-known due to their scienti- fic productivity. Some notable achievements of the IMII include neural therapies for treating melanoma and prostate cancer; the development of a vaccine against the respiratory syncytial virus, and new diagnostic methods to investigate infections and pathological endocrinological and inflammatory infections and conditions. These technologies are being assessed in different phases of clinical studies, for transfer to the population in the medium term. Since 2016, the IMII is the only member of the Southern Cone that belongs to the International Net- work of Centers of Excellence of the Federation of Clinical Immunology Societies (FOCIS; http://focisnet.org) , an initiative that provides tools for conducting clinical studies. Hosting Institutions: Pontificia Universidad Católica de Chile, Universidad de Chile and Universi- dad Andrés Bello. Lines of Research Immunology of Tumors. Infectious diseases. Endocrinological and Inflammatory Illnesses. Autoimmune illnesses.